Compounds > rivastigmine
Page last updated: 2024-08-16

rivastigmine and Amphetamine Abuse

rivastigmine has been researched along with Amphetamine Abuse in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Croft, DE; De La Garza, R; Jaeggi, S; Kalechstein, AD; Mahoney, JJ; Yoon, JH1
De la Garza, R; Yoon, JH1
Aziziyeh, A; De La Garza, R; Haile, CN; Mahoney, JJ; Nerumalla, CS; Newton, TF; Yoon, JH1
Culbertson, C; De La Garza, R; Mahoney, JJ; Newton, TF; Shoptaw, S1

Trials

4 trial(s) available for rivastigmine and Amphetamine Abuse

ArticleYear
Low dose, short-term rivastigmine administration does not affect neurocognition in methamphetamine dependent individuals.
    Pharmacology, biochemistry, and behavior, 2011, Volume: 99, Issue:3

    Topics: Adolescent; Adult; Amphetamine-Related Disorders; Attention; Cognition; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Methamphetamine; Middle Aged; Neuroprotective Agents; Phenylcarbamates; Rivastigmine; Time Factors; Young Adult

2011
Evaluation of the effects of rivastigmine on cigarette smoking by methamphetamine-dependent volunteers.
    Progress in neuro-psychopharmacology & biological psychiatry, 2011, Dec-01, Volume: 35, Issue:8

    Topics: Adolescent; Adult; Amphetamine-Related Disorders; Cholinesterase Inhibitors; Cross-Over Studies; Double-Blind Method; Humans; Methamphetamine; Middle Aged; Phenylcarbamates; Rivastigmine; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome

2011
Rivastigmine reduces "Likely to use methamphetamine" in methamphetamine-dependent volunteers.
    Progress in neuro-psychopharmacology & biological psychiatry, 2012, Apr-27, Volume: 37, Issue:1

    Topics: Adult; Amphetamine-Related Disorders; Behavior, Addictive; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Methamphetamine; Phenylcarbamates; Rivastigmine

2012
The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers.
    Pharmacology, biochemistry, and behavior, 2008, Volume: 89, Issue:2

    Topics: Adolescent; Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Choice Behavior; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Female; Humans; Male; Methamphetamine; Middle Aged; Phenylcarbamates; Psychiatric Status Rating Scales; Rivastigmine; Self Administration; Substance Abuse, Intravenous

2008